Ligand Pharmaceuticals (LGND) Q2 2025 Earnings Call August 07, 2025 08:30 AM ET Company ParticipantsMelanie Herman - Executive Director - IR & FP&ATodd Davis - CEO & DirectorPaul Hadden - SVP - Investments & Business DevelopmentTavo Espinoza - CFOLauren Hay - Vice President - Strategic Planning & Investment AnalyticsConference Call ParticipantsTrevor Allred - Senior Analyst - BiotechnologyDouglas Miehm - Healthcare AnalystMatthew Hewitt - Senior Research AnalystLarry Solow - Partner & Managing director - Eq ...

Ligand Pharmaceuticals (LGND) Q2 2025 Earnings Call August 07, 2025 08:30 AM ET Speaker0Good day, and welcome to the Ligand Second Quarter twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Question speakers' session. There And finally, I would like to advise all participants that this call is being recorded.Thank you. I'd now like to welcome Melanie Herman, Executive Director of Inve ...